Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

05 Aug 2022
0

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

Tags

Share this

Related Posts

Oncogenic roles of serine-threonine kinase receptor-associated protein (STRAP) in osteosarcoma. Pruksakorn D, Klangjorhor J, Lirdprapamongkol K, Teeyakasem P, Sungngam P, Chaiyawat P, Phanphaisarn A, Settakorn J, Srisomsap C*. Cancer Chemother Pharmacol. 2018 Dec;82(6):1039-1047.
Phytochemical profiling of Thai Centella asiatica: identification of new polyacetylene glucosides and analytical considerations in HPLC-UV analysis of triterpenoids

Recent Posts